InvestorsHub Logo
Followers 22
Posts 1993
Boards Moderated 0
Alias Born 04/11/2007

Re: None

Thursday, 05/06/2021 9:23:35 AM

Thursday, May 06, 2021 9:23:35 AM

Post# of 345793
From the ADCT 6k today... "On April 23, 2021, the FDA approved the commercial use of ZYNLONTA for the treatment of relapsed or refractory diffuse large B-cell lymphoma. The Company believes that it has sufficient commercial-grade drug product in stock for the foreseeable future and has plans in place with its contract manufacturing organizations to conduct additional manufacturing at the appropriate time."...r
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News